9,11b-Epoxidetriamcinolone, with the CAS number 215095-77-5, is a synthetic glucocorticoid steroid that exhibits anti-inflammatory and immunosuppressive properties. This compound is characterized by its epoxide functional group, which contributes to its biological activity. It is derived from triamcinolone, a well-known corticosteroid, and is utilized in various therapeutic applications, particularly in the treatment of inflammatory conditions and autoimmune disorders. The presence of the epoxide ring enhances its reactivity and interaction with biological targets, potentially leading to increased efficacy in modulating immune responses. As a glucocorticoid, it functions by binding to glucocorticoid receptors, influencing gene expression, and subsequently regulating the synthesis of proteins involved in inflammation and immune response. The compound is typically administered in a controlled manner to minimize side effects associated with corticosteroid therapy. Its pharmacokinetics, including absorption, distribution, metabolism, and excretion, are crucial for determining its therapeutic window and safety profile in clinical use.

9,11b-Epoxidetriamcinolone

215095-77-5: 9,11b-Epoxidetriamcinolone, with the CAS number 215095-77-5, is a synthetic glucocorticoid steroid that exhibits anti-inflammatory and immunosuppressive properties. This compound is characterized by its epoxide functional group, which contributes to its biological activity. It is derived from triamcinolone, a well-known corticosteroid, and is utilized in various therapeutic applications, particularly in the treatment of inflammatory conditions and autoimmune disorders. The presence of the epoxide ring enhances its reactivity and interaction with biological targets, potentially leading to increased efficacy in modulating immune responses. As a glucocorticoid, it functions by binding to glucocorticoid receptors, influencing gene expression, and subsequently regulating the synthesis of proteins involved in inflammation and immune response. The compound is typically administered in a controlled manner to minimize side effects associated with corticosteroid therapy. Its pharmacokinetics, including absorption, distribution, metabolism, and excretion, are crucial for determining its therapeutic window and safety profile in clinical use.

<p>Please enquire for more information about 9,11b-Epoxidetriamcinolone including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

CAS 215095-77-5

9,11b-Epoxidetriamcinolone

9,11b-Epoxidetriamcinolone

Ref: 3D-FE152426